Artigo de periodico

Long-term use of ticagrelor in patients with prior myocardial infarction (2015)

• Authors:
  • Bonaca, Marc P.
  • Bhatt, Deepak L.
  • Cohen, Marc
  • Steg, Philippe Gabriel
  • Storey, Robert F.
  • Jensen, Eva C.
  • Magnani, Giulia
  • Bansilal, Sameer
  • Fish, M. Polly
  • Im, Kyungah
  • Bengtsson, Olof
  • Ophuis, Ton Oude
  • Budaj, Andrzej
  • Theroux, Pierre
  • Ruda, Mikhail
  • Hamm, Christian
  • Goto, Shinya
  • Spinar, Jindrich
  • Nicolau, José Carlos
  • Kiss, Robert G.
  • Murphy, Sabina A.
  • Wiviott, Stephen D.
  • Held, Peter
  • Braunwald, Eugene
  • Sabatine, Marc S.
  • Marin Neto, José Antonio
• USP affiliated authors: NICOLAU, JOSÉ CARLOS - FM ; MARIN NETO, JOSE ANTONIO - FMRP
• Unidades: FM; FMRP
• DOI: 10.1056/NEJMoa1500857
• Subjects: FATORES DE RISCO; INFARTO DO MIOCÁRDIO; ADESÃO À MEDICAÇÃO
• Language: Inglês
• Imprenta:
  • Publisher place: Boston
  • Date published: 2015
• Source:
  • Título do periódico: The New England Journal of Medicine
  • ISSN: 0028-4793
  • Volume/Número/Paginação/Ano: v. 372, n. 19, 1791-1800, 2015

Informações sobre o DOI: 10.1056/NEJMoa1500857 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: bronze

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  BONACA, Marc P. et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, v. 372, n. 19, 2015Tradução . . Disponível em: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260. Acesso em: 04 maio 2024.

• APA

  Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., et al. (2015). Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, 372( 19). doi:10.1056/NEJMoa1500857

• NLM

  Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2024 maio 04 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260

• Vancouver

  Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2024 maio 04 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Resumo Executivo: Diretrizes da SBC sobre Angina Instável e Infarto Agudo do Miocárdio Sem Supradesnível do Segmento ST
• Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
• Vorapaxar in the secondary prevention of atherothrombotic events
• Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
• Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
• Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
• Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
• Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
• Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54